Table 2.
Prevalence of the main cardiovascular risk factors and metabolic syndrome
| EDSS 0–3.5 n = 152 |
EDSS 4.0–10 n = 70 |
Total n = 222 |
p-value | |
|---|---|---|---|---|
| MetS prevalence, % | 28.9 | 35.7 | 31.1 | 0.311 |
| MetS components, % | ||||
| BMI >28.8 kg/m2 | 30.9 | 30.0 | 30.6 | 0.890 |
| BP >130/85 mmHg (or treatment) |
30.8 | 40.0 | 33.7 | 0.199 |
| Triglycerides >150 mg/dL (or treatment) |
14.5 | 22.9 | 17.1 | 0.123 |
| Fasting blood glucose >110 mg/dL | 11.7 | 10.0 | 11.2 | 0.772 |
| HDL-c < 40 (men) or <50 (women) mg/dL | 36.8 | 42.9 | 38.7 | 0.393 |
| Number of components, SD | 1.4 (1,3) | 1.7 (1,5) | 1.5 (1,4) | 0.265 |
| Total | ||||
| 1 | 28.9 | 24.3 | 27.5 | 0.532 |
| 2 | 11.2 | 10.0 | 10.8 | 0.822 |
| 3 | 23.0 | 22.9 | 23.0 | 0.758 |
| 4 | 5.3 | 10.0 | 6.8 | 0.163 |
| 5 | 0.7 | 2.9 | 1.4 | 0.234 |
| Cardiovascular risk factors, mean (SD) | ||||
| Systolic BP, mmHg | 127.3 (14.8) | 127.9 (15.9) | 127.6 (15.5) | 0.870 |
| Diastolic BP, mmHg | 74.5 (10.1) | 76.2 (9.9) | 75.4 (10.0) | 0.726 |
| BMI, kg/m2 | 25.9 (4.5) | 26.1 (4.6) | 26.0 (4.5) | 0.949 |
| Glucose, mg/dL | 93.2 (17.6) | 93 (19.1) | 93.1 (18.1) | 0.985 |
| HbA1c, % | 5.8 | 5.8 | 5.8 | 0.255 |
| Triglycerides, mg/dL | 105.7 (50.0) | 115.1 (49.4) | 108.7 (49.9) | 0.545 |
| Total cholesterol, mg/dL | 198.4 (38.0) | 202.2 (41.5) | 199.6 (39.1) | 0.691 |
| LDL-C, mg/dL | 119.5 (36.5) | 124.1 (39.6) | 121.0 (37.4) | 0.458 |
| HDL-C, mg/dL | 59.2 (17.5) | 60.3 (17.2) | 59.5 (17.4) | 0.366 |
| Serum creatinine, mg/dL | 1.1 (0.1) | 1.1 (0.1) | 1.1 (0.1) | 0.888 |
| High cardiovascular risk, % | 12.0 | 15.7 | 14.4 | 0.658 |
BP Blood Pressure; BMI Body Mass Index; EDSS Expanded Disability Status Scale; HbA1c Glycated Haemoglobin; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; MetS Metabolic Syndrome; SD Standard Deviation